Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer

被引:133
作者
Choi, Yeonjoo [1 ]
Kim, Jin Won [1 ]
Nam, Kyung Han [2 ]
Han, Song-Hee [3 ]
Kim, Ji-Won [1 ]
Ahn, Sang-Hoon [4 ]
Park, Do Joong [4 ]
Lee, Keun-Wook [1 ]
Lee, Hye Seung [3 ]
Kim, Hyung-Ho [4 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Hematol & Med Oncol,Dept Internal Med, 82 Gumi Ro, Seongnam Si 13620, Gyeonggi Do, South Korea
[2] Inje Univ, Haeundae Paik Hosp, Dept Pathol, Coll Med, 875 Haeun Daero, Busan 48108, South Korea
[3] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, 82 Gumi Ro, Seongnam Si 13620, Gyeonggi Do, South Korea
[4] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, 82 Gumi Ro, Seongnam Si 13620, Gyeonggi Do, South Korea
关键词
Neutrophil-lymphocyte ratio; Prognostic nutritional index; Immune cell; Tumor microenvironment; Gastric cancer; NEUTROPHIL-LYMPHOCYTE RATIO; PROGNOSTIC NUTRITIONAL INDEX; INFILTRATING T-LYMPHOCYTES; BREAST-CANCER; SURVIVAL; NIVOLUMAB; PREDICT; TRASTUZUMAB; EXPRESSION; POOR;
D O I
10.1007/s10120-016-0642-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The neutrophil-lymphocyte ratio (NLR) and the prognostic nutritional index (PNI) are markers of systemic inflammation known to be useful prognostic indicators of malignancy. However, little evidence has defined the influence of inflammation on the tumor microenvironment. Two hundred eighty-eight patients who underwent curative surgery for gastric cancer were included. Preoperative peripheral blood samples were used to analyze the NLR and PNI. The optimal cutoff levels for the NLR and PNI were defined by receiver operating characteristic curve analysis for survival (NLR = 2.7, PNI = 47.7). The densities of specific immune cells (CD3(+), CD4(+), CD8(+)) within the tumor microenvironment were measured in tumor microarrays by immunohistochemical analysis. Two hundred thirty-five patients (81.6 %) had a low NLR and 53 patients (18.4 %) had a high NLR. One hundred seventeen patients (40.6 %) had a low PNI and 171 patients (59.4 %) had a high PNI. CD3(+) and CD8(+) immune cell density were not associated with the NLR and PNI. However, in the high-NLR group compared with the low-NLR group, CD4(+) immune cell density was significantly decreased (P < 0.001). Similarly, the density of CD4(+) immune cells was also significantly decreased in the low-PNI group compared with the high-PNI group (P = 0.007). A high NLR and a low PNI were correlated with worse overall survival in multivariate analysis (P = 0.028 and P = 0.002 respectively). The NLR and PNI are associated with the density of CD4(+) immune cells in the tumor microenvironment, which leads to prognostic values of systemic inflammation in gastric cancer.
引用
收藏
页码:602 / 611
页数:10
相关论文
共 39 条
[1]
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma [J].
Anraku, Masaki ;
Cunningham, Kristopher S. ;
Yun, Zhihong ;
Tsao, Ming-Sound ;
Zhang, Li ;
Keshavjee, Shaf ;
Johnston, Michael R. ;
de Perrot, Marc .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (04) :823-829
[2]
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab [J].
Bjoern, Jon ;
Nitschke, Nikolaj Juul ;
Iversen, Trine Zeeberg ;
Schmidt, Henrik ;
Fode, Kirsten ;
Svane, Inge Marie .
ONCOIMMUNOLOGY, 2016, 5 (04)
[3]
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].
Borghaei, H. ;
Paz-Ares, L. ;
Horn, L. ;
Spigel, D. R. ;
Steins, M. ;
Ready, N. E. ;
Chow, L. Q. ;
Vokes, E. E. ;
Felip, E. ;
Holgado, E. ;
Barlesi, F. ;
Kohlhaeufl, M. ;
Arrieta, O. ;
Burgio, M. A. ;
Fayette, J. ;
Lena, H. ;
Poddubskaya, E. ;
Gerber, D. E. ;
Gettinger, S. N. ;
Rudin, C. M. ;
Rizvi, N. ;
Crino, L. ;
Blumenschein, G. R. ;
Antonia, S. J. ;
Dorange, C. ;
Harbison, C. T. ;
Finckenstein, F. Graf ;
Brahmer, J. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639
[4]
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer [J].
Bremnes, Roy M. ;
Al-Shibli, Khalid ;
Donnem, Tom ;
Sirera, Rafael ;
Al-Saad, Samer ;
Andersen, Sigve ;
Stenvold, Helge ;
Camps, Carlos ;
Busund, Lill-Tove .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) :824-833
[5]
Influence of human immune cells on cancer: studies at the University of Colorado [J].
Bruno, Tullia C. ;
French, Jena D. ;
Jordan, Kimberly R. ;
Ramirez, Oscar ;
Sippel, Trisha R. ;
Borges, Virginia F. ;
Haugen, Bryan R. ;
McCarter, Martin D. ;
Waziri, Allen ;
Slansky, Jill E. .
IMMUNOLOGIC RESEARCH, 2013, 55 (1-3) :22-33
[6]
Cai T, 2006, ONCOL REP, V16, P329
[7]
Inflammation-related factors predicting prognosis of gastric cancer [J].
Chang, Wen-Jun ;
Du, Yan ;
Zhao, Xin ;
Ma, Li-Ye ;
Cao, Guang-Wen .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) :4586-4596
[8]
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[9]
Dunn Gavin P, 2007, Cancer Immun, V7, P12
[10]
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer [J].
Fox, P. ;
Hudson, M. ;
Brown, C. ;
Lord, S. ;
Gebski, V. ;
De Souza, P. ;
Lee, C. K. .
BRITISH JOURNAL OF CANCER, 2013, 109 (01) :147-153